Professor Stephen MacMahon AO
Stephen is one of the founders of The George Institute for Global Health, an architect of its global expansion and currently holds the position of Principal Director of The George Institute for Global Health (worldwide).
He also holds professorial appointments in medicine at UNSW Sydney and the University of Oxford (UK), where he is a Oxford Martin Senior Fellow. Stephen is an international authority on the causes, prevention and treatment of cardiovascular diseases and has a special interest is the management of chronic and complex conditions in resource-poor settings, particularly in the Asia-Pacific region.
In addition to his Institute and university appointments, Stephen has held several external appointments, including former Chair of the International Scientific Board of the UK BioBank. He is also Executive Chair of George Clinical Pty Ltd, a wholly owned subsidiary of The George Institute. He sits on the Boards of several other not-for-profit organisations, including the Oxford Health Alliance.
Stephen has published more than 300 scientific papers and delivered more than 200 invited lectures. For his work in the field of cardiovascular disease, he has received numerous awards, fellowships and honours from various governments, universities and learned societies.
Professor Robyn Norton AO
Robyn Norton is co-founder and Principal Director of The George Institute for Global Health. She is Professor of Global Health & Oxford Martin Senior Fellow, University of Oxford; Professor of Public Health, Faculty of Medicine, UNSW Sydney; and Honorary Professor at Peking University.
Professor Norton has published widely and is internationally regarded for her research on the causes, prevention and management of injuries, especially road traffic and fall-related injuries, as well as the management of various critical conditions in surgical and intensive care settings. She was the inaugural Chair and is now Chair Emeritus of the Road Traffic Injuries Research Network, a network supported by the World Bank and the WHO, aimed at building research capacity and research agendas, to address the growing burden of road traffic injuries in low and middle income countries.
She has had a long-standing commitment to improving women’s health and currently leads The George Institute’s research, implementation and advocacy efforts, aimed at improving the health of women and girls worldwide. Most recently she was the lead author on a University of Oxford supported policy paper entitled “Women’s Health: A New Global Agenda”, calling for a greater focus on addressing the burden of non-communicable diseases in women and the importance of a gendered approach to the collection and utilisation of health data.
此外，Robyn教授长期致力于改善妇女健康，她是《妇女健康: 全新全球议程(Women’s Health: A New Global Agenda)》政策文件的主要作者。报告由英国牛津大学发布，其目的是提高慢性病防控在妇女健康议程中的比重，并且呼吁使用性别分类方法来实施健康数据分析，从医疗卫生角度减少性别不平等。作为推动妇女健康议程全球对话的系列报告开篇之作，最终目标是通过驱使政策转变以挽救更多生命。
Professor Vlado Perkovic
Vlado Perkovic is Executive Director of The George Institute, Australia; Professor of Medicine, UNSW Sydney; and a Staff Specialist in Nephrology at the Royal North Shore Hospital.
His research focus is in clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He leads several major international clinical trials, serves on the Steering Committees of several others, and has led the development of George Clinical, the global clinical trials arm of The George Institute. He has been involved in developing Australian and global guidelines in kidney disease, cardiovascular risk assessment and blood pressure management.
Vlado holds a Doctor of Philosophy from the University of Melbourne and completed his undergraduate training at The Royal Melbourne Hospital. He is a member of the National Health and Medical Research Council Principal Committee on Research Translation; is Chair of the International Society of Nephrology Action for Clinical Trials (ISN-ACT) group; and is a Fellow of the Royal Australasian College of Physicians, of the Australian Academy of Health and Medical Sciences and of the American Society of Nephrology.
Professor Vivekanand Jha
Professor Vivekanand Jha is the Executive Director at The George Institute for Global Health, India, and a James Martin Fellow at The George Institute for Global Health, University of Oxford. He is a physician with a specialisation in the area of kidney diseases and serves on the international advisory boards of several organisations.
Prior to joining The George Institute, he was Professor of Nephrology and Head, Department of Translational Regenerative Medicine and Officer-In-Charge, Medical Education and Research Cell at the PGIMER (Postgraduate Institute of Medical Education and Research) in Chandigarh, India.
Vivek serves on the international advisory boards of several organisations, including membership of the WHO Expert Advisory Panel on Human Cell, Tissue and Organ Transplantation, and the executive committee of the International Society of Nephrology.
He is a councillor of the International Society of Nephrology, a member of the education committees for the International Transplantation Society and International Society of Peritoneal Dialysis.
He is a physician with a specialisation in the area of kidney diseases and he focuses on emerging public health threats globally and in India. He is particularly interested in using multi-disciplinary approaches and innovation to address the major challenge posed to humanity by non-communicable diseases.
According to a 2016 analysis, Vivek was an author of one of the top 1% most highly cited papers in his field worldwide.
Professor Terry Dwyer
Terry is a non-communicable disease epidemiologist with extensive experience in the conduct of cohort and case control studies. He was previously Director of the Murdoch Children’s Research Institute at the Royal Children’s Hospital, Melbourne, coordinating research projects including those on cancer, heart disease, multiple sclerosis, childhood asthma, and diabetes.
His work has focussed on infant and child health. His team's research on Sudden Infant Death Syndrome and sleeping position was recognised by the NHMRC, Australia, as one of the most important contributions to medical research by Australia in the 20th Century. Much of this work was conducted on the 11,000 infants enrolled in the Tasmanian Infant Health Survey (TIHS) between 1988 and 1995 and was supported by funds from both NH&MRC and NIH.
He is currently playing a leading role in two large global cohort collaborations. The first involves a collaboration of birth cohorts in more than ten countries to obtain prospective evidence on the causes of childhood cancer. Little prospective data on this association has previously been available. This consortium, the International Childhood Cancer Cohort Consortium (14C), seeks to assemble data on approximately 1 million mothers and babies who will be followed through childhood. It has been supported financially by NCI, and currently Terry is working on this from IARC.
The second study is focused on following around 40,000 subjects who were first measured at school age and are now moving into their fourth and fifth decades. The CDAH study is one of six coborts in three countries contributing data to this consortium. This study seeks to estimate the separate effect of childhood physical and lifestyle characteristics on risk of major adult diseases such as type 2 diabetes and cardiovascular disease. There have been many publications on this including one in the New England Journal of Medicine in 2011.
In his work Terry has developed skills in the development of environmental and lifestyle measures, in genetic measures, and the analysis of gene-environment interactions, particularly in the setting of cohort studies, including those set in early life.
Amit manages Operations and Finance for India offices at The George Institute for Global Health. He is a member of the Institute of Chartered Accountants of India and holds a graduate degree in Commerce from Delhi University.
Amit instantly connected with George Institute’s mission and values and is very passionate about being instrumental in driving policy changes in India. Prior to joining us, he worked in the services industry with companies providing services in auditing and consulting, shipping and logistics, online classifieds/advertising and internet and technology based solutions.
Professor Anthony Rodgers
Professor Rodgers has a track record in cardiovascular disease prevention, innovation and public-private partnerships, with an interest in scale-able interventions to address major risks to health. He is currently Acting Director of the Cardiovascular Division at The George Institute, Australia.
After graduating in medicine in the United Kingdom he trained in epidemiology and public health in New Zealand. He was the Principal Author of the 2002 World Health Report, the main annual publication for WHO. Professor Rodgers has led developments of an affordable four-in-one cardiovascular combination pill ('polypill'). He led a clinical trial program in economically developed and developing countries, funded by the Wellcome Trust, European Union and others.
Professor Rodgers also developed a world first cell phone based smoking cessation programme for youth, which disseminated proven health support messages in an age-appropriate, affordable medium. Over 6,000 patients were involved in clinical trials that demonstrated a 50% increase in quit rates. The service has been rolled out by Departments of Health in NZ, UK and India, with over 2 million users to date. A follow-on program delivering cognitive behavioural therapy for depression prevention was successfully trialled among 1,200 at-risk teenagers.
Professor Anushka Patel
Anushka is a Professor of Medicine, UNSW Sydney and a cardiologist at Royal Prince Alfred Hospital in Sydney, Australia. She undertook her medical training at the University of Queensland, with subsequent postgraduate research degrees from Harvard University and the University of Sydney.
As the Chief Scientist of the George Institute for Global Health, she has a key role in developing and supporting global strategic initiatives across the organisation. Her personal research interests focus on developing innovative solutions for delivering affordable and effective cardiovascular care in the community and in acute care hospital settings.
Anushka currently leads research projects relating to these interests in Australia, China and India. She is supported by a Senior Research Fellowship from the Australian National Health and Medical Research Council (NHMRC).
Professor Bruce Neal
Bruce Neal is a Senior Director at The George Institute for Global Health; Professor of Medicine, UNSW Sydney; and Chair of the Australian Division of World Action on Salt and Health.
Dr Neal is a UK-trained physician who has 20 years research experience in the clinical, epidemiological, and public health fields with a focus on heart disease, stroke and diabetes. Bruce has a longstanding interest in the environmental determinants of high blood pressure and the potential for changes in the food supply to deliver health gains. His work has been characterised by its focus on collaboration, quantitation, translation and impact. He holds professorial appointments at UNSW Sydney, Imperial College London, Flinders University in South Australia, an honorary appointment at the University of Sydney and chairs the Australian Division of World Action on Salt and Health. He has published some 300 scientific papers and in 2016 was identified by Thomson Reuters as one of ‘The World’s Most Influential Scientific Minds’, an acknowledgement provided to just 3000 researchers across all disciplines, worldwide. He has particular expertise in salt reduction but also a broader knowledge of food policy issues related to sugars, fats, portion size and food labelling.
Professor Christine Jenkins
Christine Jenkins is Head of the Respiratory Group at The George institute for Global Health; Senior Staff Specialist in Thoracic Medicine at Concord Hospital, Sydney; Clinical Professor and Head of Respiratory Discipline at University of Sydney; and Professor of Respiratory Medicine at UNSW Sydney.
Christine has been Principal Investigator and has led many investigator-initiated and competitively funded clinical trials in airways disease. She has had major roles in advocacy and leadership for lung health in Australia, chairing the National Asthma Campaign, the Federal Government’s National Asthma Advisory Group and many local and international guidelines and implementation initiatives to enhance resources, skills, capacity and clinical outcomes in airways disease. She was president of the Thoracic Society of Australia and New Zealand from 2007 - 2009.
Christine is an active clinician, and teaches and supervises medical students, advanced trainees and post graduate students. Her area of research interest is the clinical management of airways disease and patient reported outcomes in response to therapeutic interventions, and she is currently implementing trials in asthma and COPD management and pulmonary rehabilitation in Australia and Asia. Christine has written two books on asthma, one for medical students and one for patients, their families and carers. In 2002 she was made a Member in the Order of Australia for recognition of service to respiratory medicine as a physician, administrator and educator, especially in the field of asthma education.
She is on the Board of the Lung Foundation Australia, and is a member of the Thoracic Society of Australia and New Zealand, the American Thoracic Society, European Respirator Society and the Asia-Pacific Society of Respirology.
Professor Craig Anderson
Professor Craig Anderson is Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and is in part-time clinical practice as a neurologist at Royal Prince Alfred Hospital, Sydney, Australia. He is Executive Director of The George Institute China at Peking University Health Science Center in Beijing, China.
Craig holds specialist qualifications in clinical neurology and geriatrics, a PhD in medicine and epidemiology from The University of Western Australia, and is a Senior Principal Research Fellow of the National Health and Medical Research Council (NHMRC) of Australia. He is a past President of the Asia Pacific Stroke Organisation and the Stroke Society of Australasia, and is a member of several specialist societies and an editor for the Cochrane Stroke Group. He has published widely on the clinical and epidemiological aspects of stroke, cardiovascular disease and aged care, and has led several large-scale investigator-initiated epidemiological and clinical trials that have had a major influence on clinical practice guidelines for stroke treatment and prevention.
Craig Anderson教授是乔治全球健康研究院（澳大利亚）神经与精神健康部门高级主管、乔治全球健康研究院（中国）所长、澳大利亚新南威尔士大学卒中医学与临床神经科学教授。Craig Anderson教授在临床神经学和老年保健学方面拥有专业资格，并在西澳大学获得医学和流行病学博士学位，他还是澳大利亚国家健康与医学研究委员会（NHMRC）高级主管研究员。
Professor Clara Chow
Professor Clara Chow is a cardiologist committed to reducing the burden of cardiovascular disease through prevention and innovative approaches to achieve this. She is Program Director Community Based Cardiac Services, Westmead Hospital and Professor of Medicine, Western Clinical School, Sydney Medical School, University of Sydney.
She has a PhD in Medicine from the University of Sydney and completed a postdoc in Cardiovascular epidemiology and clinical trials at McMaster University, Canada. Clara holds a Career Development Fellowship of the NHMRC co-funded by the National Heart Foundation. She has over 100 publications, focused on clinical and community approaches to cardiovascular prevention and including papers in leading international journals. She led the initial TEXT ME trial that showed text messaging programs were effective in lowering cholesterol, blood pressure and weight in patients with coronary heart disease.
Erika has over 20 years Human Resources experience in Australia, USA, Europe and Asia. Experienced in all facets of HR leadership, with a particular emphasis on change management and communications/engagement.
Prior organisations include AMP, Citigroup and Colgate-Palmolive.
Professor John Chalmers AC
John Chalmers has an outstanding record in hypertension research, both fundamental and clinical. His groundbreaking research on the role of the brain in the development of hypertension led to his election to Fellowship of the Australian Academy of Science and helped establish Flinders University as a leading international centre in hypertension and neuroscience research.
His studies on the treatment of high blood pressure for the prevention of heart attack and stroke have changed the way patients are treated throughout the world. His work has been recognised through many awards including the Wellcome Medal, the RT Hall Prize of the Cardiac Society of Australia and New Zealand, The Zanchetti Lifetime Achievement Award of the European Society of Hypertension and the Volhard Medal of the International Society of Hypertension.
He has been President or Chairman of the Australian Society of Medical Research, The Royal Australasian College of Physicians, the National Health and Medical research Council of Australia, the WHO Expert Committee on Hypertension, the International Society of Hypertension and the Scientific Advisory Board of the World Heart Federation.
Professor Chalmers' contribution to medical science has been acknowledged through the award of many Honorary Doctoral degrees and extensive appointments on national and international boards and advisory committees. He was appointed a Companion in the Order of Australia (AC) in 1991 and an Officer in the National Order of Merit of France in 2010.
John Chalmers remains an active researcher at The George Institute Australia, where he is a principal investigator on many research grants and Chair of steering committees for major studies, mentors young clinical researchers from around the world, and continues to publish and lecture prolifically.
Professor John Knight
John joined The George Institute in March 2014 and has since contributed to a variety of academic and business projects in Australia, in China and with George Clinical.
His current work with the Renal and Metabolic Division includes a prospective national cohort study of Dialysis Outcomes in India.
In 2015 he convened the Steering Committee and chaired the Judges Panel for the Affordable Dialysis Prize.
He is now the Medical Director of Ellen Medical Devices Pty Ltd, a new Australian company founded to build and test a prototype of the winning entry.
Professor John Myburgh AO
Professor John A Myburgh AO, is Professor of Intensive Care Medicine, University of New South Wales; Director of the Division of Critical Care and Trauma at the George Institute for International Health and Senior Intensive Care Physician at the St George Hospital, Sydney.
He holds honorary Professorial appointments at the University of Sydney and Monash University School of Public Health and Preventive Medicine.
He has an extensive research track record over 25 years and is regarded as a national and international expert in catecholamine neurophysiology and pharmacology, trials of clinical management of traumatic brain injury, fluid resuscitation and in the development and co-ordination of over 35 clinical trials in Intensive Care Medicine.
His list of publications and success in recurrent grant funding is in the top 1% of Intensive Care physicians in Australia and within the top 5% internationally. These include over 250 refereed research publications, (including 9 papers in the New England Journal of Medicine) and 45 book chapters and monographs. He holds a Practitioner Fellowship and has received over $42M grant funding from the National Health and Medical Research Council. In addition to other national international grants, total cumulative research funding to the present is over A$70M. He has delivered over 400 presentations at national and international scientific meetings since 1994, including over 50 plenary presentations at major scientific congresses.
He is a Foundation Member and Past-Chairman of the Australian and New Zealand Intensive Care Society Clinical Trials Group. He was instrumental in the establishment of the Australian and New Zealand Intensive Care Research Centre at the Monash University School of Public Health and Preventive Medicine.
In 2006, he was appointed to establish the Division of Critical Care and Trauma at the George Institute for Global Health and has developed programs of research including new opportunities for clinician-researchers.
In addition to his research profile, he has made a substantive contribution to education in Intensive Care Medicine, both at undergraduate and postgraduate levels over the last 25 years. He was instrumental in establishing the College of Intensive Care Medicine, serving as a Fellowship examiner for twelve years, on the Board for ten years and as the first elected President from 2010-2012.
He is a current Council Member for the World Federation of Societies of Intensive and Critical Care Medicine and Fellow of the Australian Academy of Health and Medical Science.
In the 2014 Queen’s Birthday honours, he was made an Officer of the Order of Australia (AO) for distinguished service to medicine as an intensive care medical practitioner, educator and researcher, and as an international innovator in patient management.
Dr John Wastell
John joins the George Institute from the Walter and Eliza Hall Institute of Medical Research, where he was Head of Information Technology Services. There he led a major IT capability upgrade and technology refresh as the Institute doubled in size.
John’s career started in science, with a PhD in nuclear physics from the University of Melbourne. This was followed by a number of IT leadership roles in various industries, including insurance, ISP, defense and aerospace and global professional services.
Associate Professor Laurent Billot
Laurent is a senior biostatistician with 20 years of experience in health research. He is Director of the Statistics Division at the George Institute for Global Health and Associate Professor, Faculty of Medicine, UNSW Sydney.
He is responsible for providing statistical services to the George Institute and its collaborators in Australia and globally. He holds a Master of Science in Statistics and Computer Science and a Master of Research in Public Health (Biostatistics). He is an accredited statistician by the Statistical Society of Australia (AStat).
Associate Professor Martin Gallagher
Martin is an Associate Professor at UNSW Sydney, Associate Professor of Medicine at Concord Hospital Clinical School (part of the Sydney Medical School), Director of the Renal and Metabolic Division in the George Institute and a clinical nephrologist in the Renal Dept at Concord Repatriation and General Hospital. He works extensively in the ANZ Society of Nephrology in renal guidelines and clinical policy.
Martin’s research interests include large scale clinical trials to explore ways to improve the outcomes of patients with kidney disease (esp in the setting of acute kidney injury), extending the follow up of such clinical trials to understand the long term effects of treatments, measurement of health systems and the means of applying research evidence into practice.
Dr. Pallab K. Maulik
Pallab leads Research department at The George Institute for Global Health, India. He trained as a psychiatrist at All India Institute of Medical Sciences, New Delhi, received training in public health at the London School of Hygiene and Tropical Medicine, as well as Johns Hopkins School of Public Health where he pursued his Masters and Doctoral training. He brings a wealth of experience to the Institute, with an expertise in mental health.
Dr. Maulik has worked with the World Health Organisation (WHO), Geneva on Project Atlas and other mental health programs, and clinically as a psychiatrist in India and Australia.
His particular research interests include social determinants of health, especially mental health services, mental disorders, international mental health, and intellectual disability.
He is an Intermediate Career Wellcome Trust/DBT India Alliance Fellow and is leading a program called SMART Mental Health, which is on provision of mobile-based affordable evidence based mental health services in rural India.
Peter Dolnik is the Director of Research Services at The George Institute. His career has spanned both the academic and research management sectors. For a number of years, he had taught philosophy at various universities in Sydney and since 2000 he has worked in the area of research management at senior levels.
Key responsibilities associated with his latter role have included research-related compliance work, development of policies on research management as well as pre-award and post-award coordination of research funding.
Professor Rebecca Ivers
Professor Rebecca Ivers is the Director of the Injury Division at The George Institute. She is an injury epidemiologist who holds a Masters degree in Public Health and PhD in injury epidemiology from the University of Sydney. She has an appointment as Professor of Public Health at UNSW Sydney, is an honorary professor at the University of Sydney, a Professor at Flinders University, and is a member of the NSW Road Safety Advisory Council. Rebecca has published widely in the peer reviewed literature in the fields of road traffic injury and falls prevention.
Rebecca has research interests that span a broad range of topics, including novice drivers, motorcycle helmets in Asia and heavy vehicle research. She is passionate about the need to decrease road injury in vulnerable road users in the low and middle income countries of the region and is actively engaged in research with this aim. She is particularly interested in injury prevention among Indigenous communities.
Rebecca has written several book chapters on road injury for international audiences, including manuals for the World Health Organization. She leads a strong team of researchers working on road injury studies in Australia, India, China and Vietnam.
Richard Mills joins the George Institute from the World Bank, where he was most recently Director of Corporate Communications. There he helped lead efforts to tell the story of a World Bank that more than doubled its support to developing countries during the financial crisis while becoming more focused on openness, results and accountability. He spearheaded the use of new and creative tools across social media, marketing and outreach.
A spokesman for some of the highest profile parts of the United States government, from Congress to the Executive Office of the President to the State Department, Mr Mills has 20 years of experience with international issues in over 60 countries, from trade, economics, conflict and, most recently, poverty and development.
加入乔治健康研究所之前，Richard Mills在世界银行工作并任职企业沟通总监。他负责宣传世界银行的相关新闻与故事，世界银行在金融危机期间为发展中国家提供双倍于之前的支持，同时更加注重信息的公开、工作成果和问责制。他率先使用新型创造性方法进行社会化媒体、 市场营销和推广等工作。
Tim is the current COO & CFO of The George Institute for Global Health. He has extensive experience in the health, property and services industries, including as former COO of top 50 ASX-listed Mirvac Group, CEO of TJS Services, Commercial Manager for the Sydney Organising Committee for the Olympic Games and Senior Manager at PricewaterhouseCoopers.
Tim is currently a Director (and former President) of Financial Executives Institute of Australia and a former Director of Thomas & Coffey and Vice-Chair of the Australian Theatre for Young People. He holds a Bachelor of Economics from the University of Sydney and is a Fellow of the Australian Institute of Company Directors, the Institute of Chartered Accountants and the Australian Property Institute.
Tim Regan现任乔治的首席运营官和财务官。 在加入乔治前，他曾任Mirvac集团首席运营官、TJS集团执行总裁、悉尼奥林匹克运动会组织委员会商务经理以及普华永道高级经理。他有着丰富的专业知识和管理经验。